3 results
Approved WMOPending
To establish the MaximumTolerated Dose, Dose Limiting Toxicities, and the safety profile of BMS-833923 administered in combination with cisplatin and capecitabine as first-line therapy. To describe preliminary evidence of tumor response as measured…
Approved WMOPending
The study*s main objective is the creation and testing of a *SID Pain App* that in connection with a *smart sock* will fast and reliably detect nociceptive pain in persons with severe intellectual and motor disability (SID).
Approved WMORecruiting
To study the safety and efficacy of prolonged (>2 hours) end-ischemic DHOPE, by assessing the occurrence of (serious) adverse events during machine perfusion and within 30 days after liver transplantation.